Hong Kong stocks surged in late trading, with Polaris Biotechnology (06955.HK) rising more than 16%. Its subsidiary Dular Tangleptide Biologics' similar drug BA5101 has been approved for listing.
According to the Wise Finance app, Boan Biotech (06955.HK) surged over 16% in the last trading session, with a gain of 10.89% to HK$18.94 at the time of writing, with a trading volume of HK$645 million.
Latest